*ST南糖(000911.SZ)就掛牌轉讓環江遠豐公司75%股權 已簽署股權轉讓合同
格隆匯12月19日丨*ST南糖(000911.SZ)公佈,公司在北部灣產權交易所集團股份有限公司(“產權交易所”)公開掛牌轉讓所持有的廣西環江遠豐糖業有限責任公司(“環江遠豐公司”)75%股權,經產權交易所公開掛牌競價,廣西信澤環豐投資合夥企業(有限合夥)(“廣西信澤”)為受讓方,受讓價格為1元。2019年12月18日,南寧糖業完成與受讓方股權轉讓合同的簽署,並將股權轉讓合同提交至產權交易所。2019年12月19日,公司收到產權交易所轉來的受讓方支付的股權轉讓款1.00元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.